Organisation paid for research Program year 2023 Source: CMS Open Payments

Arch Clinical Trials, LLC

Neither a doctor nor a teaching hospital

Research payments

$380,253

229 payments

Through program year 2023, Arch Clinical Trials, LLC is reported as receiving $380,253 in research payments, across 229 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$9,300	1
2022	Research	$60,158	33
2021	Research	$183,381	75
2020	Research	$87,314	86
2019	Research	$40,099	34

Breakdown

Who paid Research payments · program years 2019–2023

Alkermes, Inc. $225,980 207 payments
Avanir Pharmaceuticals, Inc. $114,237 18 payments
Corcept Therapeutics $40,036 4 payments

Studies the money was for Research payments · program years 2019–2023

18-Avp-786-207 $114,237 18 payments
A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder $100,115 48 payments
A Study to Evaluate the Effect of ALKS 3831 Compared to OLANZAPINE on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness $97,176 141 payments
Cort118335-877 $40,036 4 payments
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 $23,689 17 payments
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) $5,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.